講演・口頭発表等 - 中島　友紀

分割表示  164 件中 1 - 20 件目  ／  全件表示 >>

  1. 卿芸凡、小野岳人、小原幸弘、渡邉淳、小木曽昇、伊東昌子、中島友紀、竹下淳. Emilin2 は骨再生における間葉系細胞の遊走を促進する. 第48回日本炎症・再生医学会 2024.07.19 福岡

  2. 小野岳人、傳田良亮、権藤理夢、河崎万鈴、木下佑理、中島友紀. ケミカルライブラリーを用いた新規スクリーニング法による運動器疾患の治療薬探索. 第4回日本骨免疫学会 2018.06.24 沖縄

  3. Tomoki Nakashima. Bone homeostasis and mechanomedicine. 第95回 日本生理学会 2018.03.29 高松

  4. Tomoki Nakashima. Bone homeostasis and mechano-biology. The 94th Annual Meeting of the Physiological Society of Japan 2017.03.28 Hamamatsu

  5. Tomoki Nakashima . Regulation of bone remodeling . 3nd Seoul Symposium on Bone Health KSBMR-JSBMR joint symposium 2015.05.27 Seoul

  6. M. Hayashi, T. Nakashima, and H. Takayanagi. Regulation of bone metabolism by Semaphorin 3A derived from osteoblastlineage cells.. ASBMR 2014 Annual Meeting 2014.09.13

  7. Tomoki Nakashima. Young investigator workshop1:Experience of doing a postdoc.. 国際骨代謝学会・日本骨代謝学会第2回 合同国際会議（IBMS-JSBMR 2013） 2013.05.28

  8. Tomoki Nakashima. Regulation of bone remodeling by osteocytes. . 第22回国際リウマチシンポジウム/第57回日本リウマチ学会 2013.04.19

  9. Tomoki Nakashima, Mikihito Hayashi, Hiroshi Takayanagi . Osteocyte-derived RANKL in bone remodeling. ASBMR 2012 Annual Meeting 2012.09.13

  10. Osteocyte-derived RANKL in bone remodeling.. ASBMR 2012 Annual Meeting 2012.09.12

  11. Tomoki Nakashima . Osteoprotection by semaphoring 3A. 22nd Annual Scientific Meeting ANZBMS and Asia-Pacific Bone and Mineral Research Meeting. 2012.09.03 Australia

  12. Tomoki Nakashima, Mikihito Hayashi, Hiroshi Takayanagi. Osteocyte-derived RANKL in bone metabolism.. International Conference on Osteoimmunology. 2012.06.20 Greece

  13. Tomoki Nakashima. The crucial role of osteocyte-derived RANKL in bone homeostasis. . 1st Bio-Rheumatology International Congress (BRIC2011), 8th GARN Meeting. 2011.11.15

  14. Tomoki Nakashima. The crucial role of osteocyte-derived RANKL in bone homeostasis. . 2nd Tokyo-Shanghai Workshop on Rheumatology 2011 2011.11.15

  15. Tomoki Nakashima . Regulation of bone remodeling by osteoclastogenesis. . 7th Meeting of Bone Biology Forum. 2010.08.21 Shizuoka

  16. Tomoki Nakashima, Mikihito Hayashi, Hiroshi Takayanagi.. Identification of novel genes regulated by NFATc1 in osteoclastogenesis.. The 26th Naito Conference on "Osteobiology" 2009.11.04

  17. Mikihito Hayashi, Tomoki Nakashima, Noriko Toyama-Sorimachi, Hiroshi Takayanagi. . Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation. . 3rd International Conference on Osteoimmunology 2009.06.04

  18. T, Nakashima. The crucial role of RANKL in bone loss and cancer metastasis. . he 13th Congress of the Asia Pacific League of Associations for Rheumatology (APLAR 2008). 2008.09.26

  19. A. Suematsu, Y. Tajiri, T, Nakashima, S. Ochi, H. Oda, K. Nakamura, S. Tanaka, H. Takayanagi. Effect of combined use of anti-rheumatic drugs on osteoclast differentiation. . The 13th Congress of the Asia Pacific League of Associations for Rheumatology (APLAR 2008) 2008.09.24

  20. M. Hayashi, T, Nakashima, H. Takayanagi. NFATc1-dependent programme of osteoclast differentiation and function. . The 13th Congress of the Asia Pacific League of Associations for Rheumatology (APLAR 2008). 2008.09.24

< 前のページ - 次のページ >

このページの先頭へ▲